Danaher Corporation (DHR)
NYSE·Healthcare·Medical - Diagnostics & Research
$180.21
-0.32%
Mkt Cap $130.44B
Analyst Ratings
Buy
13
Hold
4
Sell
0
Price Target (45 analysts)
$253.75
Range $220.00 – $270.00
Implied Upside
+40.8%
Consensus $253.75 vs current $180.21